{"id":6211,"date":"2021-03-26T12:55:25","date_gmt":"2021-03-26T12:55:25","guid":{"rendered":"http:\/\/www.caltagmedsystems.co.uk\/information\/?p=6211"},"modified":"2022-03-10T12:26:30","modified_gmt":"2022-03-10T12:26:30","slug":"cellvo-matrix-plus-from-stembiosys","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/cellvo-matrix-plus-from-stembiosys\/","title":{"rendered":"CELLvo™ Matrix Plus from StemBioSys"},"content":{"rendered":"

\"StemBioSys<\/a>CELLvo™ Matrix Plus from StemBioSys<\/a> is the next generation of CELLvo™ Matrix technology. Proudly distributed in the UK and Europe by Caltag Medsystems, CELLvo™ matrices are the only substrates that aim to recapitulate the biochemical, structural and mechanical cues of the native niche by leaving the extracellular matrix intact. Cell-derived matrices create a biologically-relevant culture environment for a variety of cell types by providing all the cues cells expect to receive in vivo,<\/em> in a culture dish. This means that instead of responding to foreign culture conditions, cells respond to your experimental variables.<\/p>\n

Initially developed for pluripotent stem cell culture, StemBioSys have subsequently discovered that CELLvo™ Matrix Plus is the ideal substrate for cardiomyocyte maturation and culture<\/strong>. Try CELLvo™ Matrix Plus Today!<\/a><\/p>\n

Contact us<\/a><\/p>\n

\n

Application Protocol:\u00a0 Plating iCell\u00ae Cardiomyocytes2 on CELLvoTM MATRIX PLUS<\/h1>\n

CELLvoTM MATRIX PLUS has recently been recommended for the culture of FujiFilm iCell Cardiomyocytes, one of the most recognised in vitro<\/em> models for studying heart disease and adverse cardiac drug reactions.<\/p>\n

Download Application Protocol Here<\/a><\/p>\n

\"application<\/a><\/p>\n

\n

Webinar: Drs. Travis Block and Todd Herron Discuss CELLvo™ Matrix Plus for Cardiomyocyte Maturation<\/h1>\n